VSSL

VSSL appears to refer most directly, in the life science-adjacent context, to a company that built predictive tools for the cannabis industry rather than a therapeutic biotech or healthcare company. The company used molecular and bioinformatics tools to support customers with germplasm analysis and related predictive capabilities. Available business database sources indicate that this VSSL was acquired by DigiPath in March 2020. There is no clear evidence that the company developed human therapeutics, ran a drug pipeline, or operated as a pharma, biotech, CRO, or healthcare delivery company. Accordingly, it is better characterized as an acquired cannabis/ag-bioinformatics technology company than as a healthcare company.